Latest Commercialization News

Page 40 of 481
Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.
Ada Torres
Ada Torres
24 Feb 2026
Spacetalk Ltd has signed a non-binding MOU with Vodafone Australia to distribute its Family Safety software platform, marking a strategic shift towards a software-led business model and aiming for significant recurring revenue growth.
Sophie Babbage
Sophie Babbage
24 Feb 2026
SKS Technologies Group has reported a robust half-year performance, driven by a landmark $130 million data centre contract and a strategic acquisition, positioning it strongly for FY26 growth.
Sophie Babbage
Sophie Babbage
24 Feb 2026
Abacus Group has reported a strong turnaround with a $47.6 million net profit for the half-year to December 2025, maintaining steady funds from operations and declaring a consistent interim distribution. The group is also exploring internalising management of its key joint venture, Abacus Storage King.
Eva Park
Eva Park
24 Feb 2026
Calix Limited reported a solid 21% revenue increase for the half-year ending December 2025, but losses ballooned by 250%, raising questions about the path to profitability.
Sophie Babbage
Sophie Babbage
24 Feb 2026
Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.
Ada Torres
Ada Torres
24 Feb 2026
Alicanto Minerals is launching an extensive 50,000-metre drilling campaign at its newly acquired Mt Henry Gold Project in Western Australia, aiming to expand and upgrade its existing 0.9 million ounce gold resource.
Maxwell Dee
Maxwell Dee
24 Feb 2026
Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.
Ada Torres
Ada Torres
24 Feb 2026
Vysarn Limited has reported a record first half for FY26 with revenue hitting $66.8 million and NPBT nearly doubling year-on-year to $10 million. The company reaffirms its full-year $20 million NPBT target, supported by strong industrial and advisory segment growth despite timing challenges in technology projects.
Victor Sage
Victor Sage
24 Feb 2026
PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.
Ada Torres
Ada Torres
23 Feb 2026
Nickel Industries reported a reduced loss after tax of $41.2 million for 2025, underpinned by steady production and strategic progress on its ENC HPAL project and sustainability initiatives.
Maxwell Dee
Maxwell Dee
23 Feb 2026
TMK Energy Limited reveals strong pilot well results and a robust phased development plan for its Gurvantes XXXV Coal Seam Gas project in Mongolia, underpinned by independently certified resources and strategic partnerships.
Maxwell Dee
Maxwell Dee
23 Feb 2026